Key result
VA-ECMO-supported percutaneous coronary intervention may be a feasible option for patients with severe aortic valve stenosis prior to transcatheter aortic valve replacement.
Answers are grounded in this paper and cite their sources.
VA-ECMO-supported PCI may be a feasible option for patients with severe aortic stenosis and multivessel coronary artery disease prior to TAVR.
We describe a case of successful veno-arterial extracorporeal membrane oxygenation (VA-ECMO)-supported percutaneous coronary intervention (PCI) for multivessel coronary artery disease in a patient considered as a candidate for transcatheter aortic valve replacement (TAVR). VA-ECMO-supported PCI for patients with severe aortic valve stenosis might be a feasible option before TAVR.
No takes yet. Share an insight, caveat, or question.
Ishibashi et al. (2020) studied this question. VA-ECMO-supported percutaneous coronary intervention may be a feasible option for patients with severe aortic valve stenosis prior to transcatheter aortic valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: